Publications:

The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.

Cell Reports. Medicine

Essegian, Derek D; Khurana, Rimpi R; Stathias, Vasileios V; Schürer, Stephan C SC

Publication Date: 2020-10-20

Variant appearance in text: EGFR: A92F

PubMed Link: 33205077

Variant Present in the following documents:

• Main text

View BVdb publication page

Clinical development of CAR T cell therapy in China: 2020 update.

Cellular & Molecular Immunology

Wei, Jianshu J; Guo, Yelei Y; Wang, Yao Y; Wu, Zhiqiang Z; Bo, Jian J; Zhang, Bin B; Zhu, Jun J; Han, Weidong W

Publication Date: 2021-04

Variant appearance in text: EGFR: A92F

PubMed Link: 32999455

Variant Present in the following documents:

• Main text

View BVdb publication page

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.

Cell Proliferation

Wang, Jianmin J; Zhou, Pu P; Wang, Xudong X; Yu, Yongxin Y; Zhu, Guangkuo G; Zheng, Linpeng L; Xu, Zihan Z; Li, Feng F; You, Qiai Q; Yang, Qiao Q; Zhuo, Wenlei W; Sun, Jianguo J; Chen, Zhengtang Z

Publication Date: 2019-05

Variant appearance in text: EGFR: A92F

PubMed Link: 30848009

Variant Present in the following documents:

• Main text

View BVdb publication page